First Page | Document Content | |
---|---|---|
![]() Quality-adjusted life year Pharmacoeconomics Cataract National Institute for Health and Clinical Excellence Incremental cost-effectiveness ratio Cost-effectiveness analysis Randomized controlled trial Cost–utility analysis Himalayan Cataract Project Health economics Health Medicine | Add to Reading List |
![]() | Microsoft Word - valuing healthDocID: 1qVy7 - View Document |
![]() | BRIEFING PAPER DEPARTMENT OF HEALTH PROPOSALS FOR INCLUDING BURDEN OF ILLNESS INTO VALUE BASED PRICING: A DESCRIPTION AND CRITIQUEDocID: 1qMvT - View Document |
![]() | THE INCORPORATION OF HEALTH BENEFITS IN COST UTILITY ANALYSIS USING THE EQ-5D REPORT BY THE DECISION SUPPORT UNIT Allan Wailoo, Sarah Davis, Jonathan ToshDocID: 1oVjN - View Document |
![]() | Variations in cell therapy reimbursement across the Big5EU Jesper Jorgensen and Panos KefalasDocID: 1otSK - View Document |
![]() | Do Chiropractic Physician Services for Treatment of Low Back and Neck Pain Improve the Value of Health Benefit Plans? An Evidence-Based Assessment of Incremental Impact on Population Health and Total Health Care SpendingDocID: 1osGu - View Document |